Circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)

被引：0
|
作者：
Lucci, A.
Hall, C.
Hess, K.
Ravenberg, E.
Clayborn, A.
Mittendorf, E.
Rauch, G.
Candelaria, R.
Moulder, S.
Thompson, A.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P3-01-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-01-01
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy
    Ryan, P. D.
    Tung, N. M.
    Isakoff, S. J.
    Golshan, M.
    Richardson, A.
    Corben, A. D.
    Smith, B. L.
    Gelman, R.
    Winer, E. P.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Intrinsic subtype and response to neoadjuvant chemotherapy with carboplatin and docetaxel (TCb) in triple-negative breast cancer (TNBC)
    Echavarria Diaz-Guardamino, I.
    Lopez-Tarruella, S.
    Garcia-Saenz, J. A.
    Gomez Moreno, H.
    Moreno, F.
    Jerez, Y.
    Fuentes, H.
    Marquez-Rodas, I.
    Cebollero, M.
    Del Monte-Millan, M.
    Picornell, A.
    Massarrah, T.
    Barnadas, A.
    Prat, A.
    Ballesteros Garcia, A.
    Colomer Bosch, R.
    Pelaez, B.
    Gonzalez-Rivera, M.
    Perou, C. M.
    Martin, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Pathological Response Assessment to Neoadjuvant Chemotherapy in Breast Cancer Patients Utilizing Circulating Tumour Cells (CTCs)
    Huang, Yanmei
    Fitzgerald, Marie
    Spillane, Cathy
    Ffrench, Brendan
    O'Brien, Cathal
    Ruttle, Carmel
    Bogdanska, Anna
    Martin, Cara
    Mullen, Dorinda
    Kennedy, John
    O'Toole, Sharon
    O'Leary, John
    LABORATORY INVESTIGATION, 2018, 98 : 73 - 73
  • [44] Pathological Response Assessment to Neoadjuvant Chemotherapy in Breast Cancer Patients Utilizing Circulating Tumour Cells (CTCs)
    Huang, Yanmei
    Fitzgerald, Marie
    Spillane, Cathy
    Ffrench, Brendan
    O'Brien, Cathal
    Ruttle, Carmel
    Bogdanska, Anna
    Martin, Cara
    Mullen, Dorinda
    Kennedy, John
    O'Toole, Sharon
    O'Leary, John
    MODERN PATHOLOGY, 2018, 31 : 73 - 73
  • [45] Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
    Talamantes, Sarah
    Xie, Eric
    Costa, Ricardo L. B.
    Chen, Melissa
    Rademaker, Alfred
    Santa-Maria, Cesar A.
    CANCER MEDICINE, 2020, 9 (19): : 6954 - 6960
  • [46] Neoadjuvant Chemotherapy and Neoadjuvant Chemotherapy With Immunotherapy Result in Different Tumor Shrinkage Patterns in Triple-Negative Breast Cancer
    Zou, Jiachen
    Zhang, Liulu
    Chen, Yuanqi
    Lin, Yingyi
    Cheng, Minyi
    Zheng, Xingxing
    Zhuang, Xiaosheng
    Wang, Kun
    JOURNAL OF BREAST CANCER, 2024, 27 (01) : 27 - 36
  • [47] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [48] Subsets of circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy
    Grigoryeva, E.
    Savelieva, O. E.
    Tashireva, L.
    Alifanov, V. V.
    Zavyalova, M. V.
    Tarabanovskaya, N. A.
    Cherdyntseva, N.
    Perelmuter, V. M.
    ANNALS OF ONCOLOGY, 2022, 33 : S173 - S173
  • [49] Circulating Tumor Cells Predict Survival after Neoadjuvant Chemotherapy in Non-Metastatic Breast Cancer
    Lucci, A.
    Hall, C.
    Karhade, M.
    Mishra, P.
    Anderson, A.
    Bedrosian, I.
    Kuerer, H. M.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S58 - S59
  • [50] Circulating Tumor Cells After Neoadjuvant Chemotherapy Predict Survival in Non-metastatic Breast Cancer
    Lucci, A.
    Lodhi, A.
    Bhattacharyya, A.
    Hall, C.
    Jackson, S.
    Singh, B.
    Krishnamurthy, S.
    Kuerer, H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S191 - S191
12345